Ascento-CDA
Discovery and remediation platform for dementia, diabetes and other age related diseases
StartupAscento-CDA is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2023. Discovery and remediation platform for dementia, diabetes and other age related diseases. The company has raised a total of $100K across 1 funding round, currently at the Seed stage. Ascento-CDA was founded by Marvin Collin, Rami Cohen, Raphael Nir. The company has 1-10 employees. Core technologies: Artificial Intelligence, Machine Learning.
With $100K in total funding, Ascento-CDA is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Beta. The company holds 1 patent.
- StageSeed
- ProductBeta
- ModelB2B
- Employees1-10
- HQJerusalem
- Last Round$250K
Marvin CollinPresident & Co-Founder
Rami CohenCEO and Co-Founder
Raphael NirChief Science Officer & Co-Founder
What does Ascento-CDA do?
Ascento-CDA is developing and will soon launch a solution, which by use of OCT scans seek to detect 65+ people at early stages of cognitive decline, diabetes and other age-related diseases and support remediation strategies. Its technology encapsulates data analysis and highly sensitive Cytokine tests, incorporated in algorithmic analysis, which allows us to issue Actionable Intelligence to enhance Healthy Aging. Ascento-CDA performed a first IRB with a clinic in New York and will now start an IRB study, which includes OCT scans, Cytokine testing and cognitive decline data. Vision is to capture a share of the 15 million OCT scans performed in the US and funnel them to our IICM technology, allowing them to identify cognitive – and other - conditions, related to age.
How much funding has Ascento-CDA raised?
Ascento-CDA has raised $100K in total funding across 1 rounds. The company is currently at the Seed stage.
Who founded Ascento-CDA?
Ascento-CDA was founded in 2023 by Marvin Collin (President & Co-Founder), Rami Cohen (CEO and Co-Founder), Raphael Nir (Chief Science Officer & Co-Founder).
What sector is Ascento-CDA in?
Ascento-CDA operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, with core technologies in Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Insurance Companies, Providers.
Where is Ascento-CDA located?
Ascento-CDA is based in Jerusalem, Israel. The company also has offices abroad.